Clin2
NCT06722950Possibly a fitNot yet recruiting

Preventing nerve pain from oxaliplatin chemotherapy

Colorectal Adenoma

Treatments studied

Part of Cancer, Pain clinical trials.

This trial tests a new drug, AC591, to see if it can prevent the nerve damage and pain that often comes with oxaliplatin chemotherapy for colorectal cancer. If you are about to start this type of chemo after surgery, this study might help reduce side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have colorectal cancer that was confirmed by a biopsy.
  • You are scheduled to receive a specific chemo regimen (CAPEOX) within 3 weeks to 2 months after surgery, and you have never had oxaliplatin before.
  • You are generally healthy enough to be up and about (ECOG score 0 or 1).
  • Your blood counts, liver, and kidney function are within acceptable ranges.
  • You are willing to use effective birth control during the study and for 3 months after the last dose.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07733817Not yet recruiting
Probiotics to reduce nerve damage from colon cancer chemo

This trial studies whether taking a daily probiotic supplement can reduce the nerve damage (neuropathy) that often happens with oxaliplatin chemotherapy. If it works, it might help you feel better and stay on your full chemo plan.

Caen, Centre François Baclesse
NCT05404230Recruiting
Preventing nerve damage from oxaliplatin in the hands and feet

This study looks at ways to prevent numbness or nerve pain in the hands and feet that can happen from oxaliplatin treatment. It includes people with colon or rectal cancer who will be getting standard chemotherapy with capecitabine plus oxaliplatin.

Aalborg
NCT07167446Recruiting· Early Phase 1
CBD to prevent nerve damage from oxaliplatin in colorectal cancer

This trial tests if cannabidiol (CBD) can prevent nerve damage (neuropathy) caused by the chemotherapy drug oxaliplatin. If you have colorectal cancer that has spread or cannot be removed by surgery and you are about to start oxaliplatin, you may be able to join.

Philadelphia, Pennsylvania
NCT07365592Recruiting· Phase 1/Phase 2
Neoadjuvant therapy for locally advanced colorectal cancer

This trial tests a combination of chemotherapy, an immunotherapy drug (anti-PD-1 antibody), and sitagliptin before surgery for colorectal cancer that has not spread to other organs. The goal is to see if this approach can shrink the tumor and improve outcomes.

Hangzhou, Zhejiang
NCT06856447Recruiting· Phase 1
Coenzyme Q10 to prevent nerve damage from chemotherapy

This trial tests whether taking coenzyme Q10 (a natural substance) can help prevent nerve damage caused by the chemotherapy drug oxaliplatin in people with stage III colorectal cancer. If successful, it could reduce pain, numbness, or tingling during treatment.

Cairo
NCT05850130Recruiting
Acupuncture for nerve pain after colon cancer treatment

This trial tests whether acupuncture can relieve the nerve pain and tingling in the hands and feet that often occurs after treatment with oxaliplatin, a chemotherapy drug for gastrointestinal cancers. The study aims to help people manage this side effect and improve their daily comfort.

Amiens

Hear when a new Colorectal Adenoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.